MRI Study – Chronic Progressive External Ophthalmoplegia
Condition(s):Chronic Progressive External OphthalmoplegiaLast Updated:April 14, 2016Completed
Hide Studies Not Open or Pending
Condition(s):Chronic Progressive External OphthalmoplegiaLast Updated:April 14, 2016Completed
Condition(s):Mitochondrial Myopathies; Mitochondrial DNA Mutation; Mitochondrial Diseases; Chronic Progressive External Ophthalmoplegia With Myopathy; Kearns-Sayre SyndromeLast Updated:April 26, 2023Recruiting
Condition(s):Mitochondrial Diseases; Mitochondrial DNA tRNALeu(UUR) m.3243A<G Mutation; Maternally Inherited Diabetes and Deafness (MIDD); Mitochondrial Encephalomyopathy, Lactic Acidosis and Stroke Like Episodes (MELAS); Chronic Progressive External Ophthalmoplegia (CPEO)Last Updated:March 6, 2024Completed
Condition(s):Blepharoptosis; Ptosis, Eyelid; Myasthenia Gravis; Stroke; Traumatic Brain Injury; Chronic Progressive External OphthalmoplegiaLast Updated:October 10, 2022Recruiting
Condition(s):Mitochondrial Diseases; Mitochondrial Myopathies; Progressive External Ophthalmoplegia; Progressive Ophthalmoplegia; Progressive; Ophthalmoplegia, External; Mitochondria DNA Deletion; MELASLast Updated:July 20, 2023Completed
Condition(s):Mitochondrial Myopathies; Mitochondrial Pathology; Mitochondrial DNA Mutation; Mitochondrial Diseases; Mitochondrial DNA Deletion; Mitochondrial DNA Depletion; Mitochondrial Metabolism Defect; Mitochondrial Complex I DeficiencyLast Updated:December 12, 2023Active, not recruiting
Condition(s):Mitochondrial Disorders; Mitochondrial Genetic Disorders; Mitochondrial Diseases; Disorder of Mitochondrial Respiratory Chain Complexes; Deletion and Duplication of Mitochondrial DNALast Updated:August 1, 2022Recruiting
Condition(s):Increased Lordosis/Scoliosis; Hyporeflexia; Duchenne Muscular Dystrophy; Red-Green Color Blindness; Lordosis; Scoliosis; Muscular Atrophy; Muscular WeaknessLast Updated:March 24, 2022Completed
Condition(s):LGMD2I; LGMDR9; Limb Girdle Muscular Dystrophy; Congenital Muscular Dystrophy; Muscle-Eye-Brain Disease; Walker-Warburg Syndrome; FKRP Gene MutationLast Updated:January 30, 2024Recruiting
Condition(s):Congenital Muscular Dystrophy With ITGA7 (Integrin Alpha-7) Deficiency; Alpha-Dystroglycanopathy (Congenital Muscular Dystrophy and Abnormal Glycosylation of Dystroglycan With Severe Epilepsy); Alpha-Dystroglycanopathy (Congenital Muscular Dystrophy With Fatty Liver and Infantile-onset Cataract Caused by TRAPPC11 Mutations); Alpha-Dystroglycanopathy (Congenital Muscular Dystrophy With Hypoglycosylation of Dystroglycan); Alpha-Dystroglycanopathy (Congenital Muscular Dystrophy With Hypoglycosylation of Dystroglycan and Epilepsy); Alpha-Dystroglycanopathy (Dystroglycanopathy, Congenital With or Without Mental Retardation (Formerly MDC1C)); Alpha-Dystroglycanopathy (Fukuyama CMD); Alpha-Dystroglycanopathy (LGMDR09 FKRP Related (Formerly LGMD2I)); Alpha-Dystroglycanopathy (LGMDR11 POMT1 Related (Formerly LGMD2K)); Alpha-Dystroglycanopathy (LGMDR13 FKTN Related (Formerly LGMD2M)); Alpha-Dystroglycanopathy (LGMDR14 POMT2 Related (Formerly LGMD2N)); Alpha-Dystroglycanopathy (LGMDR15 POMGnT1 Related (Formerly LGMD2O)); Alpha-Dystroglycanopathy (LGMDR19 GMPPB Related (Formerly LGMD2T)); Alpha-Dystroglycanopathy (LGMDR20 ISPD Related (Formerly LGMD2U)); Alpha-Dystroglycanopathy (LGMDR24 POMGnT2 Related); Alpha-Dystroglycanopathy (Muscle Eye Brain Disease (MEB)); Alpha-Dystroglycanopathy (Walker Warburg Syndrome (WWS)); Choline Kinase B Receptor – CHKB; Collagen VI Related Disorders; Collagen XII Related Disorders; Congenital Muscular Dystrophy Not Otherwise Specified (Including Merosin Positive); Congenital Muscular Dystrophy With Cataracts and Intellectual Disability (MDCCAID); Congenital Muscular Dystrophy With Joint Hyperlaxity; Congenital Muscular Dystrophy With Rigid Spine Related to ACTA1; Emery-Dreifuss Muscular Dystrophy; GOLGA2-related Congenital Muscle Dystrophy With Brain Involvement; LMNA Related Disorders; Merosin Deficient CMD (Full or Partial); Nesprin Related MD (SYNE1); SELENON Related Disorders (Previously Known as SEPN1); SELENON Related Myopathy (Aka SEPN1); Telethonin CMD; Congenital Myasthenic Syndrome; Limb-Girdle Muscular Dystrophy; LGMDD01 – DNAJB6 (Formerly LGMD1D); LGMDD05 – Collagen VI Related Bethlem Myopathy (Dominant); LGMDR07 – Telethonin (TCAP) Related (Formerly LGMD2G); LGMDR08 – TRIM Related (Formerly LGMD2H); LGMDR09 – FKRP Related (Formerly LGMD2I); LGMDR10 – Titin (TTN) Related (Formerly LGMD2J); LGMDR11 – POMT1 Related (Formerly LGMD2K); LGMDR13 – Fukutin (FKTN) Related (Formerly LGMD2M); LGMDR14 – POMT2 Related (Formerly LGMD2N); LGMDR15 – POMGnT1 Related (Formerly LGMD2O); LGMDR16 – DAG1 Related Dystroglycanopathy (Formerly LGMD2P); LGMDR17 – Plectin (PLEC) Related (Formerly LGMD2Q); LGMDR18 – TRAPPC11 Related (Formerly LGMD2S); LGMDR19 – GMPPB Related (Formerly LGMD2T); LGMDR20 – ISPD Related (Formerly LGMD2U); LGMDR22 – Collagen VI Related Bethlem Myopathy (Recessive); LGMDR23 – LAMA2 Related; LGMDR24 – POMGnT2 RelatedLast Updated:August 9, 2021Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.